NCT01503216View on ClinicalTrials.gov

Safety and Bioefficacy of Vitamin D2 and Vitamin D3

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Vitamin D Deficiency
Interventions
DIETARY_SUPPLEMENT

cholecalciferol

cholecalciferol, 2000 IU per day, 8 weeks

DIETARY_SUPPLEMENT

ergocalciferol

vitamin d2, 2000 IU per day for 8 weeks

DIETARY_SUPPLEMENT

Placebo

Placebo

All Listed Sponsors
lead

Ulrike Lehmann

OTHER

NCT01503216 - Safety and Bioefficacy of Vitamin D2 and Vitamin D3 | Biotech Hunter | Biotech Hunter